Clinical Trial: Prevention of Corticosteroid-induced Glucose Intolerance

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Treatment With Rosiglitazone for the Prevention of Glucose Intolerance in Patients Treated With Corticosteroids

Brief Summary: Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.

Detailed Summary: Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.
Sponsor: Hadassah Medical Organization

Current Primary Outcome: plasma glucose concentration [ Time Frame: 6 months ]

Original Primary Outcome: olasma glucose concentration

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Hadassah Medical Organization

Dates:
Date Received: October 16, 2005
Date Started: April 2005
Date Completion: October 2015
Last Updated: September 13, 2011
Last Verified: September 2011